Peptide Research
GHRP-2 Research: Ghrelin Receptor, GHS-R1a & Endocrine Signaling
Oct
Growth Hormone Secretagogue Research • Research Use Only
GHRP-2 is a synthetic growth-hormone-releasing peptide used in research on the growth-hormone secretagogue receptor, also known as the ghrelin receptor or GHS-R1a. It provides a model for studying endocrine signaling that is distinct from the GHRH-receptor pathway.
What Is GHRP-2?
GHRP-2 belongs to the synthetic growth-hormone secretagogue family. These compounds were studied before ghrelin was identified as the endogenous ligand for GHS-R1a. Discovery of ghrelin helped connect synthetic GHRPs to a broader receptor system involved in pituitary, hypothalamic, gastrointestinal, metabolic, and other signaling networks.
GHS-R1a: The Core Research Target
GHS-R1a is a G-protein-coupled receptor with substantial constitutive activity and complex intracellular signaling. Depending on tissue and experimental context, studies examine calcium signaling, phospholipase pathways, receptor trafficking, endocrine output, and interactions with other GPCR systems.
A detailed review of GHS-R signaling describes the receptor’s intracellular signaling and regulation across multiple systems. See The growth hormone secretagogue receptor: its intracellular signaling and regulation.
GHRP-2, Ghrelin, and GH Release
Growth-hormone secretagogues can produce GH-releasing responses through a pathway that differs from GHRH-receptor activation. Reviews of ghrelin and synthetic secretagogues describe potent and reproducible GH-release effects while also documenting activity in other endocrine and metabolic systems. See Natural and synthetic growth hormone secretagogues.
Why Compare GHRP-2 With GHRP-6?
GHRP-2 and GHRP-6 share the same broad receptor family but can produce different response profiles depending on model and endpoint. Comparative studies may examine potency, receptor activation, hormone selectivity, and downstream signaling.
GHRP-2 vs. GHRH Analogues
GHRP-2 acts through the GHS-R/ghrelin-receptor system. Sermorelin and tesamorelin primarily act through the GHRH receptor. Investigating both pathways can help researchers understand convergence at the pituitary while distinguishing upstream receptor biology.
GHRP-2 5mg at Revolt Peptides
See the GHRP-2 5mg research product page. Related materials include GHRP-6 5mg and Ipamorelin/CJC No DAC 5mg/5mg.
Common Laboratory Endpoints
- GHS-R1a receptor activation
- Calcium and second-messenger signaling
- GH-release kinetics in pituitary models
- Receptor desensitization and trafficking
- Comparative responses versus GHRP-6, ipamorelin, or GHRH analogues
Evidence Limits
The ghrelin/GHS-R system participates in many physiological processes, so a response measured in one tissue should not be assumed to represent a universal effect. Controlled receptor-specific experiments are essential.
GHRP-2 FAQ
What receptor is most associated with GHRP-2?
The growth-hormone secretagogue receptor, GHS-R1a, also known as the ghrelin receptor.
Is GHRP-2 the same as GHRH?
No. They engage different upstream receptor systems.
Browse the Research Journal for more endocrine research.
Research Use Only. Not intended for human or veterinary use.
